Pharmacokinetics, Safety, and Tolerability of SHP465 Mixed Amphetamine Salts After Administration of Multiple Daily Doses in Children Aged 4–5 Years with Attention-Deficit/Hyperactivity Disorder

BACKGROUND: Given the limited treatment options for younger children with attention-deficit/hyperactivity disorder (ADHD), a clinical study for SHP465 treatment was warranted. OBJECTIVES: We aimed to evaluate the pharmacokinetics, safety, and tolerability of SHP465 mixed amphetamine salts (MAS) 6.25...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilic, Katarina, Kugler, Alan R., Yan, Brian, McNamara, Nora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732812/
https://www.ncbi.nlm.nih.gov/pubmed/34826114
http://dx.doi.org/10.1007/s40263-021-00870-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732812/
https://www.ncbi.nlm.nih.gov/pubmed/34826114
http://dx.doi.org/10.1007/s40263-021-00870-5

Ejemplares similares